<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36071410</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Trends of key surveillance performance indicators of acute flaccid paralysis: a descriptive analysis, Uganda, 2015-2020.</ArticleTitle><Pagination><StartPage>1694</StartPage><MedlinePgn>1694</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1694</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-022-14077-w</ELocationID><Abstract><AbstractText Label="BACKGROUND">Polio is disease caused by poliovirus which can in turn cause irreversible paralytic disease, presenting as Acute Flaccid Paralysis (AFP). A sensitive AFP surveillance system, in which all reported AFP cases are evaluated, first to determine if they are true AFP cases or not, is key for tracking polio eradication. True AFP cases are then later categorized as polio AFP or non-polio AFP (NPAFP) cases. Sensitivity is defined by meeting an annual NPAFP rate/100,000 population&#x2009;&lt;&#x2009;15&#xa0;years of&#x2009;&#x2265;&#x2009;4/100,000, and an annual stool adequacy (SA) rate of&#x2009;&#x2265;&#x2009;80%. We describe Uganda's AFP surveillance performance between 2015-2020, based on the WHO-recommended indicators, including; NPAFP and stool adequacy rate.</AbstractText><AbstractText Label="METHODS">We performed a descriptive analysis of national AFP surveillance data, 2015-2020 obtained from ministry of health. We evaluated proportion of reported AFP cases that were true AFP, and changes in NPAFP and stool adequacy (SA) rate over the study period. We evaluated the trends in achieving the targeted NPAFP and SA rates from 2015-2020. We used QGIS to illustrate patterns in NPAFP and SA rates across districts and subregions.</AbstractText><AbstractText Label="RESULTS">Among 3,605 AFP cases reported and investigated countrywide from 2015-2020, 3,475 (96%) were true AFP cases. All the true AFP cases were non-polio related. District reporting was near-complete (97-100% each year). Overall, the mean NPAFP rate declined from 3.1/100,000 in 2015 to 2.1/100,000 in 2020. Less than 40% of districts met the NPAFP target rate in all years. The proportion of districts achieving the NPAFP target rate of&#x2009;&#x2265;&#x2009;4/100,000 significantly declined from 35% in 2015 to 20% in 2020. The mean annual SA rate nationally was 88% from 2015-2020. Only 66% of districts achieved the SA target rate of&#x2009;&#x2265;&#x2009;80% in the study period. The proportion of districts with SA rate&#x2009;&#x2265;&#x2009;80% significantly increased from 68 to 80% between 2015 and 2020.</AbstractText><AbstractText Label="CONCLUSION">Most districts reported AFP cases. However, there was a decline in the NPAFP rate from 2015-2020 and few districts achieved the target rate. The suboptimal AFP surveillance system performance leaves the country at risk of missing ongoing poliovirus transmission. We recommend health worker training on active AFP searches, intensified supportive supervision, increase the number of environmental surveillance sentinel sites to boost AFP surveillance in the country, and periodic review meetings with districts to assess AFP surveillance performance.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amodan</LastName><ForeName>Bob Omoda</ForeName><Initials>BO</Initials><AffiliationInfo><Affiliation>Uganda Public Health Fellowship Program, Kampala, Uganda. bomoda@musph.ac.ug.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ministry of Health Uganda, Kampala, Uganda. bomoda@musph.ac.ug.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kisakye</LastName><ForeName>Annet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>World Health Organization, Country Office, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okumu</LastName><ForeName>Patricia Thiwe</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Uganda Public Health Fellowship Program, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahirirwe</LastName><ForeName>Sherry Rita</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Uganda Public Health Fellowship Program, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadobera</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Uganda Public Health Fellowship Program, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Driwale</LastName><ForeName>Alfred</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ministry of Health Uganda, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ario</LastName><ForeName>Alex Riolexus</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Uganda Public Health Fellowship Program, Kampala, Uganda.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ministry of Health Uganda, Kampala, Uganda.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant><Grant><GrantID>U2G GH001353</GrantID><Acronym>GH</Acronym><Agency>CGH CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000629404">acute flaccid myelitis</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020805" MajorTopicYN="N">Central Nervous System Viral Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009187" MajorTopicYN="N">Myelitis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009468" MajorTopicYN="N">Neuromuscular Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014454" MajorTopicYN="N" Type="Geographic">Uganda</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AFP</Keyword><Keyword MajorTopicYN="N">Eradication</Keyword><Keyword MajorTopicYN="N">Polio</Keyword><Keyword MajorTopicYN="N">Surveillance</Keyword><Keyword MajorTopicYN="N">Uganda</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>7</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36071410</ArticleId><ArticleId IdType="pmc">PMC9449289</ArticleId><ArticleId IdType="doi">10.1186/s12889-022-14077-w</ArticleId><ArticleId IdType="pii">10.1186/s12889-022-14077-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Henderson DA. Countering the posteradication threat of smallpox and polio. Clin Infect Dis. 2002;34(1):79&#x2013;83. doi: 10.1086/323897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/323897</ArticleId><ArticleId IdType="pubmed">11731949</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin CQ, Dong HX, Sun ZX, Zhou JW, Dou CY, Lu SH, Yang RR. Acute immune thrombocytopenic purpura as adverse reaction to oral polio vaccine (OPV) Hum Vaccin Immunother. 2013;9(8):1739&#x2013;1740. doi: 10.4161/hv.24847.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.24847</ArticleId><ArticleId IdType="pmc">PMC3906275</ArticleId><ArticleId IdType="pubmed">23807364</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Surveillance standards for vaccine-preventable diseases. 2. Geneva: World Health Organization; 2018.</Citation></Reference><Reference><Citation>Fact sheets: Poliomyelitis [https://www.who.int/news-room/fact-sheets/detail/poliomyelitis]</Citation></Reference><Reference><Citation>Poliomyelitis (polio) [https://www.who.int/health-topics/poliomyelitis#tab=tab_1]</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative . Standard operating procedures: responding to a poliovirus outbreak or event, version 3. Geneva, Switzerland: Global Polio Eradication Initiative; 2019.</Citation></Reference><Reference><Citation>WHO: Vaccine-associated paralytic polio (VAPP) and vaccine-derived poliovirus (VDPV). In: Fact Sheet &#x2013; February 2015. 2015.</Citation></Reference><Reference><Citation>Dyer O. Polio: WHO declares type 3 poliovirus eradicated after 31 year campaign. BMJ. 2019;367:l6201. doi: 10.1136/bmj.l6201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l6201</ArticleId><ArticleId IdType="pubmed">31649018</ArticleId></ArticleIdList></Reference><Reference><Citation>Two out of three wild poliovirus strains eradicated [https://www.who.int/news-room/feature-stories/detail/two-out-of-three-wild-poliovirus-strains-eradicated]</Citation></Reference><Reference><Citation>World Health Organization . Polio Eradication Strategy 2022&#x2013;2026: Delivering on a promise. Geneva: WHO; 2021.</Citation></Reference><Reference><Citation>World Health Organization . Polio Endgame Strategy 2019&#x2013;2023: Eradication, interration, certification and containment. Geneva: WHO/Polio/1904; 2019.</Citation></Reference><Reference><Citation>UNEPI . A Reference Manual for Pre &amp; In-service Health Workers. Uganda National Expanded Programme on Immunization. Kampala: Ministry of Health; 2017. Immunization in Practice Uganda.</Citation></Reference><Reference><Citation>Soltani JM, Esmailnasab NM, Roshani DP, Karimi MM. Amjadi M-JM: Acute flaccid paralysis and its differential diagnosis in in kurdistan province, Western iran; an 11-year surveillance. Iran J Pediatr. 2014;24(2):131&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4268831</ArticleId><ArticleId IdType="pubmed">25535530</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez M, Akbar IE, Wadood MZ, Shukla H, Jorba J, Ehrhardt D. Progress toward poliomyelitis eradication - Afghanistan, January 2019-July 2020. MMWR Morb Mortal Wkly Rep. 2020;69(40):1464&#x2013;1468. doi: 10.15585/mmwr.mm6940a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6940a3</ArticleId><ArticleId IdType="pmc">PMC7561224</ArticleId><ArticleId IdType="pubmed">33031360</ArticleId></ArticleIdList></Reference><Reference><Citation>National Population Projections by Single age and sex (2015&#x2013;2040) [https://www.ubos.org/?pagename=explore-publications&amp;p_id=20]</Citation></Reference><Reference><Citation>QGIS Geographic Information System. Open Source Geospatial Foundation Project [http://qgis.osgeo.org]</Citation></Reference><Reference><Citation>Tegegne AA, Fiona B, Shebeshi ME, Hailemariam FT, Aregay AK, Beyene B, Asemahgne EW, Woyessa DJ, Woyessa AB. Analysis of acute flaccid paralysis surveillance in Ethiopia, 2005&#x2013;2015: progress and challenges. Pan Afr Med J. 2017;27(Suppl 2):10&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5578723</ArticleId><ArticleId IdType="pubmed">28890751</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesfaye B, Sowe A, Kisangau N, Ogange J, Ntoburi S, Nekar I, Muitherero C, Camara Y, Gathenji C, Langat D, et al. An epidemiological analysis of acute flaccid paralysis (AFP) surveillance in Kenya, 2016 to 2018. BMC Infect Dis. 2020;20(1):611. doi: 10.1186/s12879-020-05319-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05319-6</ArticleId><ArticleId IdType="pmc">PMC7437168</ArticleId><ArticleId IdType="pubmed">32811467</ArticleId></ArticleIdList></Reference><Reference><Citation>Davarpanah MA, Bakhtiari H, Mehrbani D, Khadem AlhosseinI F. A 12-years surveillance of poliomyelitis and acute flaccid paralysis in fars province, Southern Iran. Iranian Red crescent Med J (IRCMJ). 2008;10(4):288-93.</Citation></Reference><Reference><Citation>Miles M, Ryman TK, Dietz V, Zell E, Luman ET. Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature. Vaccine. 2013;31(12):1560&#x2013;1568. doi: 10.1016/j.vaccine.2012.10.089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.10.089</ArticleId><ArticleId IdType="pubmed">23196207</ArticleId></ArticleIdList></Reference><Reference><Citation>Odoom JK, Ntim NA, Sarkodie B, Addo J, Minta-Asare K, Obodai E, Eshun M, Ahove VV, Diamenu S, Adjabeng M, et al. Evaluation of AFP surveillance indicators in polio-free Ghana, 2009&#x2013;2013. BMC Public Health. 2014;14:687. doi: 10.1186/1471-2458-14-687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-14-687</ArticleId><ArticleId IdType="pmc">PMC4094438</ArticleId><ArticleId IdType="pubmed">24996415</ArticleId></ArticleIdList></Reference><Reference><Citation>Manyanga D, Byabamazima C, Masvikeni B, Daniel F. Assessment of acute flaccid paralysis surveillance performance in East and Southern African countries 2012&#x2013;2019. Pan Afr Med J. 2020;36:71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7380870</ArticleId><ArticleId IdType="pubmed">32754298</ArticleId></ArticleIdList></Reference><Reference><Citation>Okiror S, Ogange J, Shukla H, Lamoureau C, Monze M, Ismail A, Kazoka A, Nkowane B, Kamadjeu R, Igweonu O, et al. Surveillance Review System to Track Progress Towards Polio Eradication in the Horn of Africa. J Immunol Sci. 2021;Spec Issue(2):1111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7610761</ArticleId><ArticleId IdType="pubmed">33997863</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AT, Sodha S, Warren WC, Sergon K, Kiptoon S, Ogange J, Ahmeda AH, Eshetu M, Corkum M, Pillai S, et al. Forewarning of poliovirus outbreaks in the horn of Africa: an assessment of acute flaccid paralysis surveillance and routine immunization systems in Kenya. J Infect Dis. 2014;210(suppl_1):S85&#x2013;S90. doi: 10.1093/infdis/jiu149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu149</ArticleId><ArticleId IdType="pmc">PMC4638114</ArticleId><ArticleId IdType="pubmed">25316880</ArticleId></ArticleIdList></Reference><Reference><Citation>Fergus CA, Storer E, Arinaitwe M, Kamurari S, Adriko M. COVID-19 information dissemination in Uganda: perspectives from sub-national health workers. BMC Health Serv Res. 2021;21(1):1061. doi: 10.1186/s12913-021-07068-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-021-07068-x</ArticleId><ArticleId IdType="pmc">PMC8496434</ArticleId><ArticleId IdType="pubmed">34620175</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Easing COVID-19 impact on key health services. 2020.</Citation></Reference><Reference><Citation>Ministry of Health. Declaration of Polio outbreak in Uganda. Kampala: Ministry of Health; 2021.</Citation></Reference><Reference><Citation>Clarke A, Blidi N, Dahn B, Agbo C, Tuopileyi R, Rude MJ, Williams GS, Seid M, Gasasira A, Wambai Z, et al. Strengthening acute flaccid paralysis surveillance post Ebola virus disease outbreak 2015&#x2013;2017: the Liberia experience. Pan Afr Med J. 2019;33(Suppl 2):2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6675926</ArticleId><ArticleId IdType="pubmed">31402963</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>